KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Short term Debt (2018 - 2025)

Historic Short term Debt for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $698.4 million.

  • BioNTech SE's Short term Debt rose 16321.71% to $698.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $698.4 million, marking a year-over-year increase of 16321.71%. This contributed to the annual value of $1.5 billion for FY2024, which is 24526.66% up from last year.
  • BioNTech SE's Short term Debt amounted to $698.4 million in Q3 2025, which was up 16321.71% from $164.1 million recorded in Q2 2025.
  • BioNTech SE's Short term Debt's 5-year high stood at $11.1 billion during Q2 2022, with a 5-year trough of $157.2 million in Q2 2024.
  • Its 5-year average for Short term Debt is $1.2 billion, with a median of $466.4 million in 2025.
  • As far as peak fluctuations go, BioNTech SE's Short term Debt skyrocketed by 144137.37% in 2021, and later plummeted by 9830.46% in 2023.
  • Quarter analysis of 5 years shows BioNTech SE's Short term Debt stood at $1.4 billion in 2021, then tumbled by 41.18% to $801.0 million in 2022, then crashed by 44.23% to $446.7 million in 2023, then skyrocketed by 245.27% to $1.5 billion in 2024, then crashed by 54.72% to $698.4 million in 2025.
  • Its last three reported values are $698.4 million in Q3 2025, $164.1 million for Q2 2025, and $466.4 million during Q1 2025.